REG - AIM - AIM Notice - 27/04/2020

ChariotAnnouncement

27/04/2020 09:05

RNS Number : 8668K
  
AIM
  
27 April 2020
  
 

NOTICE
 
27/04/2020 - 08:00
 
The London Stock Exchange admits the following securities to trading on AIM:
 



AURA ENERGY LIMITED




5,807,178


ORDINARY SHARES OF NO PAR VALUE FULLY PAID (DI)


(BD1RHP4)(AU000000AEE7)



 



CONCEPTA PLC




224,875,000


ORDINARY SHARES OF 0.1P EACH, FULLY PAID


(BYZ2R30)(GB00BYZ2R301)



 



CHARIOT OIL & GAS LIMITED


BLOCK ADMISSION




12,000,000


ORDINARY SHARES OF 1P EACH, FULLY PAID


(B2R9PM0)(GG00B2R9PM06)








 



DIURNAL GROUP PLC




12,963


ORDINARY SHARES OF GBP0.05 EACH FULLY PAID


(BDB6Q76)(GB00BDB6Q760)



 



FARON PHARMACEUTICALS OY




950,000


ORDINARY SHARE OF NO PAR VALUE; FULLY PAID (DI)


(BYMKYR0)(FI4000153309)



 



FRANCHISE BRANDS PLC




11,477,167


ORDINARY SHARES OF 0.5P EACH, FULLY PAID


(BD6P7Y2)(GB00BD6P7Y24)



 



IDEAGEN PLC




5,573


ORDINARY SHARES OF 1P EACH FULLY PAID


(B0CM0C5)(GB00B0CM0C50)



 



KNIGHTS GROUP HOLDINGS PLC




1,439,568


ORDINARY SHARES OF 0.2P EACH FULLY PAID


(BFYF629)(GB00BFYF6298)



 



LOUNGERS PLC




9,250,000


ORDINARY SHARES OF 1 PENCE EACH FULLY PAID;


(BH4JR00)(GB00BH4JR002)



 



REGENCY MINES PLC




1,145,452


ORDINARY SHARES OF 0.01P EACH, FULLY PAID


(BKM6986)(GB00BKM69866)



 



SCIENCE IN SPORT PLC




12,281,902


ORDINARY SHARES OF 10P EACH FULLY PAID


(BBPV532)(GB00BBPV5329)



 
AMENDMENT
 
Following a Sub-Division the following security has been amended:
 



CONCEPTA PLC




 


ORDINARY SHARES OF 2.5P EACH, FULLY PAID


(BYZ2R30)(GB00BYZ2R301)



 
This should appear as:
 



CONCEPTA PLC




 


ORDINARY SHARES OF 0.1P EACH, FULLY PAID


(BYZ2R30)(GB00BYZ2R301)



 
If you have any queries or require further information, please contact Market Operations on 020 7797 4310.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
AMOBUGDSCSDDGGS